ADAMS STREET PARTNERS LLC
Long book
$260.3M
Q1 2026
Positions
3
Top-10 weight
100%
concentration
Last quarter
+39.4%
SPY +14.8%
Turnover
40%
of book per quarter
Strategy in plain words
auto-generated from filingsADAMS STREET PARTNERS LLC is a diversified fundamental manager, specialised in healthcare (70% of the long book), running a $260.3M US long book across 3 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: BILLIONTOONE INC CL A, RIMINI STREET INC, CORVUS PHARMACEUTICALS INC.
Over the last 9 quarters its long book ran on average 6.9pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-8.9%
Q2 2024
+4.7%
Q3 2024
+23.4%
Q4 2024
+19.2%
Q1 2025
+7.2%
Q2 2025
+30.0%
Q3 2025
-13.7%
Q4 2025
+0.8%
Q1 2026
+39.4%
Sector allocation
Healthcare 70%
Services media 30%
Long book by quarter
What does ADAMS STREET own?
Q1 2026 13F13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 3 | $260.3M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 5 | $263.9M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 5 | $153.2M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 6 | $142.0M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 7 | $113.0M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 6 | $112.8M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 6 | $181.7M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 9 | $242.7M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 12 | $251.7M | canonical | SEC ↗ |